tirzepatide court case update ruling compound Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The FDA's tirzepatide decision creates uncertainty – tirzepatide decision fda on compounded

By removing the psychological and practical barriers associated with injectable treatments, oral GLP-1s have the potential to reposition obesity care as a routine, chronic intervention rather than a specialist-led, escalation therapy

By enhancing satiety and reducing hunger, tirzepatide makes it easier for patients to stick to a healthy eating plan and achieve long-term weight loss goals

Other psychological factors, such as perfectionism, the need for control, excessive worrying and depression, also have been found to be associated with insomnia

Dont make the mistake of doing too much, too fast

Not through an approved prescription yet, because retatrutide is still investigational

Improved reimbursement is expected to be a major long-term growth driver